United States securities and exchange commission logo August 2, 2021 Bill Demers Chief Financial Officer POINT Biopharma Global Inc. Inc. 4850 West 78th Street Indianapolis, IN 46268 Re: POINT Biopharma Global Inc. Registration Statement on Form S-1 Filed July 30, 2021 File No. 333-258325 Dear Mr. Demers: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jane Park at 202-551-7439 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jon Stanley, Esq.